| |
 |
 |
| |
|
|
| WELCOME AND OPENING REMARKS |
| |
|
|
 |
Kathryn M. Carbone
M.D., Science Forum Organizing Committee
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
 |
| |
|
|
|
Norris E. Alderson
Ph.D., Associate Commissioner for Science
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
Mark B. McClellan, M.D., Ph.D.
Commissioner of Food and Drugs
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
Keith Carson
Williamsburg BioProcessing Foundation
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
| OPENING ADDRESS |
| |
|
|
|
HHS Initiatives that Protect America’s Health
Tommy Thompson
Secretary, Department of Health and Human Services
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
| KEYNOTE ADDRESS |
| |
|
|
|
Lessons from Swine Flu in an Age of Bioterrorism
Harvey V. Fineberg, M.D. Ph.D.
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
| Science: The Cornerstone of Risk Assessment and Management |
| |
|
|
|
Enhancing the Role of Science in Stakeholder-Based Risk Management Decision-Making
Gail Charnley, Ph.D.
Health Risk Strategies
(No relationships, financial or otherwise, to disclose in relation to this presentation)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
Introduction to Bioinformatics
Dan Casciano
Ph.D., National Center for Toxicological Research, FDA
(No relationships, financial or otherwise, to disclose in relation to this presentation)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
Microbial and Antimicrobial Resistance Risk Analysis: Emerging Hazards Meet Re-Emerging Science
H. Gregg Claycamp, Ph.D.
Center for Veterinary Medicine (No relationships, financial or otherwise, to disclose in relation to this presentation)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
FDA Science: Ahead of the Curve
Chaired by Norris E. Alderson, Ph.D., Associate Commissioner for Science
|
| |
|
|
|
Bacterial Evolution, Mutators, and the Emergence of Pathogens
Tom Cebula, Ph.D.
Center for Food Safety and Applied Nutrition, FDA
No relationships, financial or otherwise, to disclose in relation to this presentation
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
Cancer, Apoptosis, and Oxidative Stress: What's Protein S Got To Do With It?
Emily Shacter, Ph.D.
Center for Biologics Evaluation and Research, FDA
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
Forensic Investigation Related to Food and Pharmaceutical Tampering and Counterfeiting
S. Frank Platek, M.S.
Office of Regulatory Affairs, FDA (Includes discussion of a commercial product however he claims no interest, financial or otherwise, in the manufacturer and he will discuss case-related items/products involving tampering and/or counterfeiting of food, beverage and pharmaceutical products.)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
Public Health Initiatives in the Aftermath of 9/11
Chaired by
|
| |
|
|
|
NIH Perspectives
Elias Zerhouni, M.D.
National Institutes of Health
(No relationships, financial or otherwise, to disclose in relation to this presentation)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
Did Events of 9/11 and Later Make Us A Better FDA?
Bernard A. Schwetz, D.V.M., Ph.D.
FDA
(No relationships, financial or otherwise, to disclose in relation to this presentation)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
National Level Priorities and Preparedness
David W. Fleming, M.D.
Centers for Disease Control and Prevention D.V.M
(No relationships, financial or otherwise, to disclose in relation to this presentation)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
New Technologies for Assessing and Predicting Risk: Application of Bioinformatics
Chaired by
|
| |
|
|
|
Development of a Toxicoinformatics Integrated System at NCTR
Weida Tong, Ph.D.
National Center for Toxicological Research, FDA
(No relationships, financial or otherwise, to disclose in relation to this presentation)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
Serum Proteomic Pattern Diagnostics Using Artificial Intelligence Based Bioinformatics
Emanuel F.Petricoin, Ph.D.
Center for Biologics Evaluation and Research, FDA
(No relationships, financial or otherwise, to disclose in relation to this presentation)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
An Integration of Genomic, Proteomic, and Metabonomic ApproachesTo Better Evaluate Drug-Associated Cardiovascular Risks
Frank D. Sistare, Ph.D.
Center for Drug Evaluation and Research, FDA
(No relationships, financial or otherwise, to disclose in relation to this presentation)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
Incorporation of Toxicogenomics into Mechanistic and Predictive Toxicology: Analysis of the Effects of Ethynyl Estradiol on Uterine Gene Expression
Timothy Zacharewski, Ph.D.
Michigan State University
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
Defining Cancer Risk
Chaired by
|
| |
|
|
|
Thresholds, Risk Assessment, and Setting the Limits of Regulation
Mitchell A. Cheeseman, Ph.D.
Center for Food Safety and Applied Nutrition, FDA
(Includes discussion of commercial product and otherwise claims no relationships, financial or otherwise, to disclose in relation to this presentation)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
Using Computational Toxicology to Screen Chemicals for Carcinogenic Potential
Joseph F. Contrera, Ph.D.
Center for Drug Evaluation and Research, FDA
(Includes discussion of commercial product, and presenter has a CRADA with Multicose, Inc. and otherwise claims no relationships, financial or otherwise, to disclose in relation to this presentation.)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
Relevance of Model Somatic Mutation Systems for Humans
Richard J. Albertini, Ph.D
University of Vermont
(No relationships, financial or otherwise, to disclose in relation to this presentation)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
Unified Approach for Cancer and Non-cancer Risk Assessment
Ralph Kodell, Ph.D.
National Center for Toxicological Research, FDA
(No relationships, financial or otherwise, to disclose in relation to this presentation)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
Host Responses to Medical Interventions
Chaired by
|
| |
|
|
|
Protective Innate Immune Responses Elicited by CpG Oligonucleotides
Dennis Klinman, M.D., Ph.D.
Center for Biologics Evaluation and Research, FDA
(No relationships, financial or otherwise, to disclose in relation to this presentation)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
Replacement Heart Valve-Related Pathology: In Vivo Preclinical Studies
Stephen L. Hilbert, M.D., Ph.D.
Center for Devices and Radiological Health, FDA
(Includes discussion of a commercial product however he claims no interest, financial or otherwise, with the manufacturer and off-label use will not be discussed.)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
PET Imaging and Pharmacokinetics
Jerry Collins, Ph.D.
Center for Drug Evaluation and Research, FDA
(No relationships, financial or otherwise, to disclose in relation to this presentation)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
Cancer : Origins, Diagnosis, Treatment and Prevention
Chaired by
|
| |
|
|
|
Cytokine Receptors as Targets of Cancer Therapy
Raj K. Puri, M.D., Ph.D.
Center for Biologics Evaluation and Research, FDA
(Includes discussion of unlabeled/investigational use of a commercial product in presentation therapeutic targeted agent discovered at CBER, and has CRADA with NeoPharm, Inc., and otherwise claims no relationships, financial or otherwise, to disclose in relation to this presentation.)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
Cancer Susceptibility, Early Detection
Luke Ratnasinghe, Ph.D., M.P.H.
National Center for Toxicological Research, FDA
(No relationships, financial or otherwise, to disclose in relation to this presentation)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
Effects of Exposure to Estrogens at Various Life Stages on Reproductive Endpoints and Cancer
K. Barry Delclos, Ph.D.
National Center for Toxicological Research, FDA
(No relationships, financial or otherwise, to disclose in relation to this presentation)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
Diagnostic Imaging, Reader Variability, Computer Aids – and the Quest for the Holy Grail
Robert F. Wagner, Ph.D.
Center for Devices and Radiological Health, FDA
(No relationships, financial or otherwise, to disclose in relation to this presentation)
|
|
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
On the Scene: Detecting Biological and Security Risks
Chaired by
|
| |
|
|
|
Collaborative Efforts to Promote Diagnostic Platform Development
Maj. Wilson, Ph.D.
Department of Defense
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
Development of Real-Time PCR Tests for Agents Causing Smallpox and Anthrax
Thomas F. Smith, Ph.D.
Mayo Clinic and Foundation
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
FDA’s Role in Security Screening Systems: Radiation Risks, Privacy Laws, and Public Concern
Orhan Suleiman, Ph.D.
Office of the Commissioner, FDA
(Includes discussion of commercial product or service, and claims no relationships, financial or otherwise, to disclose in relation to this presentation.)
|
|
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
Emerging Issues in Risk Communication
Chaired by
|
| |
|
|
|
Public Participation in Risk Communication
Ned Groth III, Ph.D.
Consumers Union
(No relationships, financial or otherwise, to disclose in relation to this presentation)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
When Science and Society Conflict: A Diagnostic Model for Risk Communication
Stephen F. Sundlof, D.V.M., Ph.D.
Center for Veterinary Medicine, FDA
(No relationships, financial or otherwise, to disclose in relation to this presentation)
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
FDA and the Media: Communicating Risk to the Public
Lauran Neergaard
Associated Press
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
Internet2 Workshop
Chaired by
|
| |
|
|
|
Introduction
Mary Kratz, M.T.(A.S.C.P.)
Internet2 Health Sciences
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
The Next Generation Internet, Internet2 & the National Library of Medicine
Paul Fontelo, MD, MPH
Office of High Performance Computing and Communications
National Library of Medicine
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
The Future of Health and Internet2 of the Future
Victor Frankel, M.D.
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
| |
|
|
|
Clinical Realities
David J. Polly, Jr., M.D.
|
|
[
Modem ]
[
Broadband ]
|
[
Broadband ]
|
|
